In two different gastric cancer cell lines MKN45 and SGC7901, morusin treatment significantly reduced c-Myc expression at the mRNA and protein levels in a time- and dose-dependent manner (Wang et al., 2017). This evidence concerns the gene MYC and gastric cancer.